TGFB1 and familial pancreatic carcinoma: RAC1B has been shown to negatively affect the TGF-β signaling pathway in pancreatic cancer cells by suppressing C-terminal phosphorylation, and hence activation, of SMAD2 and SMAD3 by the ALK5 kinase [40].